Han Xu, Wu Yongzhi, Shan Yue, Zhang Xu, Liao Jinfeng
National Clinical Research Centre for Oral Diseases, State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Gels. 2021 Sep 27;7(4):155. doi: 10.3390/gels7040155.
Joint diseases that mainly lead to articular cartilage injury with prolonged severe pain as well as dysfunction have remained unexplained for many years. One of the main reasons is that damaged articular cartilage is unable to repair and regenerate by itself. Furthermore, current therapy, including drug therapy and operative treatment, cannot solve the problem. Fortunately, the micro-/nanoparticle hybrid hydrogel platform provides a new strategy for the treatment of articular cartilage-related diseases, owing to its outstanding biocompatibility, high loading capability, and controlled release effect. The hybrid platform is effective for controlling symptoms of pain, inflammation and dysfunction, and cartilage repair and regeneration. In this review, we attempt to summarize recent studies on the latest development of micro-/nanoparticle hybrid hydrogel for the treatment of articular cartilage-related diseases. Furthermore, some prospects are proposed, aiming to improve the properties of the micro-/nanoparticle hybrid hydrogel platform so as to offer useful new ideas for the effective and accurate treatment of articular cartilage-related diseases.
主要导致关节软骨损伤并伴有长期剧痛及功能障碍的关节疾病多年来一直未得到解释。主要原因之一是受损的关节软骨自身无法修复和再生。此外,包括药物治疗和手术治疗在内的现有疗法都无法解决这个问题。幸运的是,微/纳米颗粒混合水凝胶平台由于其出色的生物相容性、高负载能力和控释效果,为治疗关节软骨相关疾病提供了一种新策略。该混合平台对控制疼痛、炎症和功能障碍症状以及软骨修复和再生有效。在这篇综述中,我们试图总结关于微/纳米颗粒混合水凝胶治疗关节软骨相关疾病的最新进展的近期研究。此外,还提出了一些展望,旨在改善微/纳米颗粒混合水凝胶平台的性能,从而为有效、准确地治疗关节软骨相关疾病提供有用的新思路。